Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Baird Maintains Neutral on Quest Diagnostics, Raises Price Target to $154

Baird analyst Eric Coldwell maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $143 to $154.
byBenzinga Newsdesk
January 12, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Baird analyst Eric Coldwell maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $143 to $154.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

BlackBerry, Micron And Other Big Stocks Moving Higher In Thursday’s Pre-Market Session

By Lisa Levin
June 29, 6:21 AM
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. BlackBerry Limited (NYSE: BB) shares climbed 18.5% to $5.94 in pre-market trading after the company reported better-than-expected fiscal first-quarter results.

ALVR

Read More

Costco Wholesale , Procter & Gamble And Other Defensive Stocks From Wall Street’s Most Accurate Analysts

By Lisa Levin
November 24, 8:04 AM
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst's opinion to trust.

COST